Literature DB >> 8783697

Tuberculous meningitis in adults: review of 48 cases.

R Verdon1, S Chevret, J P Laissy, M Wolff.   

Abstract

The cases of 48 adult patients with tuberculous meningitis who were admitted to intensive care unit (ICU) between 1982 and 1993 were reviewed. An underlying disease was present in 24 patients (50%), including 10 with human immunodeficiency virus infection. Forty-seven patients were referred to the ICU because of neurological deterioration; 22 were comatose at admission. Forty-six patients received antituberculous treatment; 36 required mechanical ventilatory support, and 16 underwent neurosurgery. Thirty-one patients died within 4 months after admission, and the remaining 17 were alive at a 1-year follow-up. Univariate prognostic analysis selected three variables, all assessed at admission, associated with outcome: time to onset of treatment of > or = 3 days (P = .003), coma (P = .006), and simplified acute physiology score of > 11 (P = .03). Thus, the outcome of tuberculous meningitis is mainly determined by the clinical stage at admission and the delay in starting treatment. These findings underscore the need to initiate early therapy as soon as the diagnosis of tuberculous meningitis is suspected.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783697     DOI: 10.1093/clinids/22.6.982

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  45 in total

Review 1.  Tuberculous meningitis.

Authors:  G Thwaites; T T Chau; N T Mai; F Drobniewski; K McAdam; J Farrar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

2.  The diagnostic conundrum and treatment dilemma of a patient with a rapidly progressive encephalopathy.

Authors:  Christopher W Beatty; Claire J Creutzfeldt; Arielle P Davis; Zachary Hoffer; Sandeep P Khot
Journal:  Neurohospitalist       Date:  2014-01

3.  Diagnostic dilemma of a young man with Fever and headaches.

Authors:  Arielle P Davis; Christina M Marra; Sandeep P Khot
Journal:  Neurohospitalist       Date:  2012-10

4.  Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis.

Authors:  Nathan C Bahr; Ryan Halupnick; Grace Linder; Reuben Kiggundu; Henry W Nabeta; Darlisha A Williams; Abdu K Musubire; Bozena M Morawski; Srinand Sreevatsan; David B Meya; Joshua Rhein; David R Boulware
Journal:  Biomark Med       Date:  2018-06-01       Impact factor: 2.851

5.  Neurobrucellosis: Unexpected Answer From Metagenomic Next-Generation Sequencing.

Authors:  Kanokporn Mongkolrattanothai; Samia N Naccache; Jeffrey M Bender; Erik Samayoa; Elizabeth Pham; Guixia Yu; Jennifer Dien Bard; Steve Miller; Grace Aldrovandi; Charles Y Chiu
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

Review 6.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Approach to the Diagnosis and Management of Tuberculous Meningitis.

Authors:  Scott W. Sinner; Allan R. Tunkel
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

8.  Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US.

Authors:  Ekaterina V Kourbatova; Michael K Leonard; Javier Romero; Colleen Kraft; Carlos del Rio; Henry M Blumberg
Journal:  Eur J Epidemiol       Date:  2006-10-27       Impact factor: 8.082

9.  Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study.

Authors:  B Roca; N Tornador; E Tornador
Journal:  Epidemiol Infect       Date:  2008-01-21       Impact factor: 2.451

10.  Improved sensitivity of nucleic acid amplification for rapid diagnosis of tuberculous meningitis.

Authors:  Isik Somuncu Johansen; Bettina Lundgren; Fehmi Tabak; Björn Petrini; Salih Hosoglu; Nese Saltoglu; Vibeke Østergaard Thomsen
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.